… contrast the efficacy and safety of combining erlotinib and bevacizumab with erlotinib alone
… trials (RCTs) comparing erlotinib plus bevacizumab with erlotinib in NSCLC patients. The …

… high-quality RCTs with large sample sizes are necessary to verify our conclusions and to
further explore the efficacy and adverse events of erlotinib+bevacizumab combination therapy. …

… We found that a combination of bevacizumab and erlotinib significantly improved
progression-free survival and the overall response rate in the second-line treatment of NSCLC …

… A role for erlotinib and bevacizumab as single agents has been established in the treatment
… However, the efficacy and safety of erlotinib in combination with bevacizumab compared …

… However, the combination of angiogenesis inhibitors and TKI … of the bevacizumab and
erlotinib combination in EGFRm … safety and efficacy of the bevacizumab–erlotinib combination in …

… discontinuation owing to disease progression should be reduced, and it will be interesting
to observe whether bevacizumab is tolerable and efficacious in combination with osimertinib. …

… We then compared the efficacy and safety of second-line chemotherapies between erlotinib
plus bevacizumab and panitumumab, and erlotinib plus placebo. The goal of our study was …

… that bevacizumab combined with erlotinib significantly improved … observed in the bevacizumab
combined with erlotinib arm, … Further research should explore the efficiency of the different …

… evaluated efficacy and safety of erlotinib plus bevacizumab … for a reliable assessment of
efficacy in the smaller subgroups of … findings the erlotinib plus bevacizumab combination is not …

… Objectives Combination treatment with erlotinib plus bevacizumab has … the efficacy and safety
of erlotinib plus bevacizumab in … that the erlotinib plus bevacizumab combination prolongs …